FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079415020> ?p ?o ?g. }

• W2079415020 endingPage "1507" @default.
• W2079415020 startingPage "1507" @default.
• W2079415020 abstract "Chronomodulated chemotherapy has emerged as a new therapy as a result of recent studies focusing on the biological clock. It has been demonstrated that combination chronomodulated chemotherapy of platinum-based drugs and 5-fluorouracil (5-Fu) can significantly improve efficacy and reduce the incidence of adverse events in patients with metastatic colorectal cancer, as compared with conventional chemotherapy. However, the results may be different in different tumors. Recurrent and metastatic head and neck squamous cell carcinoma (HNSCC) is very difficult to treat, with an extremely unfavorable prognosis. So far, no report is available on chronomodulated chemotherapy for HNSCC.Retrospective analyses were made on 49 patients with local recurrent and/or metastatic HNSCC who underwent palliative treatments with paclitaxel, carboplatin, and 5-Fu. The patients were divided into a chronomodulated chemotherapy group (28 patients) and a conventional chemotherapy group (21 patients) according to their administration times. The two groups were compared for tumor objective response rate, overall survival (OS), progression-free survival (PFS), and the incidence of adverse events.The tumor objective response rate and patients' OS were significantly higher and longer in the chronomodulated chemotherapy group than in the conventional chemotherapy group (71.43% versus 42.86%, respectively, P<0.05; and median OS 15.3 months versus 10.6 months, respectively, P<0.05). However, PFS was similar statistically (median PFS 11.6 months versus 7.2 months, P>0.05). The global incidence of adverse events in the chronomodulated chemotherapy group was significantly lower than that in the conventional chemotherapy group (46.43% versus 76.19%, P<0.05), with significantly lower incidence of grade 3-4 adverse events (7.14% versus 33.33%, P<0.05).Chronomodulated chemotherapy with paclitaxel, carboplatin, and 5-Fu may be a new and effective therapy for patients with recurrent and/or metastatic HNSCC as compared with conventional chemotherapy." @default.
• W2079415020 created "2016-06-24" @default.
• W2079415020 creator A5003580079 @default.
• W2079415020 creator A5024402935 @default.
• W2079415020 creator A5044285234 @default.
• W2079415020 creator A5076415782 @default.
• W2079415020 creator A5083292183 @default.
• W2079415020 date "2013-10-01" @default.
• W2079415020 modified "2023-09-27" @default.
• W2079415020 title "Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma" @default.
• W2079415020 cites W1481846369 @default.
• W2079415020 cites W1867715023 @default.
• W2079415020 cites W1975787992 @default.
• W2079415020 cites W1978758070 @default.
• W2079415020 cites W1983970003 @default.
• W2079415020 cites W1994040396 @default.
• W2079415020 cites W1996167718 @default.
• W2079415020 cites W2020513070 @default.
• W2079415020 cites W2026004922 @default.
• W2079415020 cites W2042560813 @default.
• W2079415020 cites W2042689996 @default.
• W2079415020 cites W2084905853 @default.
• W2079415020 cites W2094938224 @default.
• W2079415020 cites W2095995750 @default.
• W2079415020 cites W2098064548 @default.
• W2079415020 cites W2114680028 @default.
• W2079415020 cites W2118991777 @default.
• W2079415020 cites W2126176842 @default.
• W2079415020 cites W2135663587 @default.
• W2079415020 cites W2139844513 @default.
• W2079415020 cites W2155184579 @default.
• W2079415020 cites W2155476547 @default.
• W2079415020 cites W2165948908 @default.
• W2079415020 cites W2183761554 @default.
• W2079415020 cites W222355177 @default.
• W2079415020 cites W2257569374 @default.
• W2079415020 doi "https://doi.org/10.2147/ott.s53098" @default.
• W2079415020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3810446" @default.
• W2079415020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24187501" @default.
• W2079415020 hasPublicationYear "2013" @default.
• W2079415020 type Work @default.
• W2079415020 sameAs 2079415020 @default.
• W2079415020 citedByCount "9" @default.
• W2079415020 countsByYear W20794150202014 @default.
• W2079415020 countsByYear W20794150202015 @default.
• W2079415020 countsByYear W20794150202017 @default.
• W2079415020 countsByYear W20794150202021 @default.
• W2079415020 countsByYear W20794150202022 @default.
• W2079415020 countsByYear W20794150202023 @default.
• W2079415020 crossrefType "journal-article" @default.
• W2079415020 hasAuthorship W2079415020A5003580079 @default.
• W2079415020 hasAuthorship W2079415020A5024402935 @default.
• W2079415020 hasAuthorship W2079415020A5044285234 @default.
• W2079415020 hasAuthorship W2079415020A5076415782 @default.
• W2079415020 hasAuthorship W2079415020A5083292183 @default.
• W2079415020 hasBestOaLocation W20794150201 @default.
• W2079415020 hasConcept C120665830 @default.
• W2079415020 hasConcept C121332964 @default.
• W2079415020 hasConcept C121608353 @default.
• W2079415020 hasConcept C126322002 @default.
• W2079415020 hasConcept C143998085 @default.
• W2079415020 hasConcept C197934379 @default.
• W2079415020 hasConcept C2776530083 @default.
• W2079415020 hasConcept C2776694085 @default.
• W2079415020 hasConcept C2776833033 @default.
• W2079415020 hasConcept C2777292972 @default.
• W2079415020 hasConcept C2778239845 @default.
• W2079415020 hasConcept C2780456651 @default.
• W2079415020 hasConcept C2781451048 @default.
• W2079415020 hasConcept C61511704 @default.
• W2079415020 hasConcept C71924100 @default.
• W2079415020 hasConceptScore W2079415020C120665830 @default.
• W2079415020 hasConceptScore W2079415020C121332964 @default.
• W2079415020 hasConceptScore W2079415020C121608353 @default.
• W2079415020 hasConceptScore W2079415020C126322002 @default.
• W2079415020 hasConceptScore W2079415020C143998085 @default.
• W2079415020 hasConceptScore W2079415020C197934379 @default.
• W2079415020 hasConceptScore W2079415020C2776530083 @default.
• W2079415020 hasConceptScore W2079415020C2776694085 @default.
• W2079415020 hasConceptScore W2079415020C2776833033 @default.
• W2079415020 hasConceptScore W2079415020C2777292972 @default.
• W2079415020 hasConceptScore W2079415020C2778239845 @default.
• W2079415020 hasConceptScore W2079415020C2780456651 @default.
• W2079415020 hasConceptScore W2079415020C2781451048 @default.
• W2079415020 hasConceptScore W2079415020C61511704 @default.
• W2079415020 hasConceptScore W2079415020C71924100 @default.
• W2079415020 hasLocation W20794150201 @default.
• W2079415020 hasLocation W20794150202 @default.
• W2079415020 hasLocation W20794150203 @default.
• W2079415020 hasLocation W20794150204 @default.
• W2079415020 hasOpenAccess W2079415020 @default.
• W2079415020 hasPrimaryLocation W20794150201 @default.
• W2079415020 hasRelatedWork W1502181122 @default.
• W2079415020 hasRelatedWork W1567229547 @default.
• W2079415020 hasRelatedWork W1989958874 @default.
• W2079415020 hasRelatedWork W2053778437 @default.
• W2079415020 hasRelatedWork W2081431504 @default.
• W2079415020 hasRelatedWork W2311734504 @default.

• next